Rare Kidney Stone Consortium

@davidsas1 Strong work, Man! and women.

@kidney_boy The hypothesis that normal HCO3 isn't the whole story with respect to acid handling is definitely out there (this ref from 2017): ncbi.nlm.nih.gov/pmc/articles/P… @weddellite

Great work as usual - chipping away at the skeptics! Well done

Just in, our paper on Kidney Transplant Outcomes in Patients with Adenine... : in Transplantation @RKSC12, @Landspitali and @uni_iceland journals.lww.com/transplantjour…

Most CKD patients die from CV disease. NIDDK says NHLBI must fund anything with CV endpoint. NHLBI won’t fund HD studies ergo there is no funding source for CV trials in ESKD. Catch 22! How do we move the needle and get NIH to fund research on a fundamental threat to our pts?

@Krystahllopathy Given your name & outstanding Twitter handle the right meetings for you: rocksociety.org/events/

@LaurenceHBeckJ1 Nice. Congrats too to @RKSC12 coauthor @LadaLadabl @NYUnephro

Coming soon to a NEJM near you ... Finally!! (The mail comes early in Boston - stay tuned for the July 4 issue, 10 years and 2 days after PLA2R) Congrats Fernando and Dan!!!

"If doctors and nurses clocked out when their paid hours were finished, the effect on patients would be calamitous....The system knows it, and takes advantage." ... the hours were part of the profession before they were exploited nytimes.com/2019/06/08/opi…

@johnasayer @NewcastleHosps They’ll sign up for nephrology - or cardiology? - training immediately afterwards! Go get ‘em John

Teaching junior docs about kidney tubules and acid base today @NewcastleHosps

@kidney_boy The guy with the big yellow head is a ringer. I don’t think that’s fair. @NYUnephro will win the day!

St John Nephrology represents #NephMadness

New work this week of @LadaLadabl and @RKSC link.springer.com/article/. Proposing cutoffs for screening proteinuria to distinguish Dent Disease (DD) from other CKDs 10.1007%2Fs00467-019-04210-0@NYUnephro

Today @nyulangone @NYUnephro

@johnasayer @jsrdf @SayerLab Wow

Kidney research uk update magazine featuring @jsrdf @SayerLab kidneyresearchuk.org/media/sign-up-…

@tony_breu The CV outcomes of thiazide-treated HTN are reduced when given with K or ENaCi or aldo antagonists. Review: ncbi.nlm.nih.gov/m/pubmed/27048…

15/Summary ✔️The goal [K+] of ≥4.0 likely derived from studies of AMI ✔️3.5-4.5 mEq/L may be more appropriate in these patients ✔️Repleting all hospitalized patients to >4 is less evidence-based ✔️Hypokalemia may lead to VT/VF via the reduced function of the Na/K-ATPase

1/ Why do we administer potassium to a goal of ≥4.0 mEq/L? As an intern, potassium (oral or IV) was likely my most common order. How did this become a key part of inpatient providers' days? Let's have a look at potassium and find out why we "replete".

It's our birthday! The first RaDaR patient was recruited 9 years ago today, on the 18th January 2010. We've come a long way since then, with over 21,000 recruits from 97 hospitals. Many thanks to our supporters @Kidney_Research @kidneycareuk @PKDCharity @RenalAssoc @RenalRegistry

I’m going to support your kids someday soon - The topic clearly appeals to nephrons - Ben told me today that he interviewed a wildlife veterinarian about salt toxicity in beavers in coastal areas...THAT is nephrology!

Very useful update on genetics of stones

Awright @davidsas1 link.springer.com/article/10.100…

And this comprehensive review of our work to develop new drugs for cystinuria by Amrik Sahota of @RutgersU ncbi.nlm.nih.gov/pubmed/30515543 @weddellite @NYUnephro @NYUUrology